hplc-analytical-chem-2018-keynote

5 / 10

Page 29
Notes:
Journal of Analytical & Bioanalytical Techniques | ISSN: 2155-9872 | Volume 9
World HPLC, Separation Techniques & Pharmacovigilance
World Analytical Chemistry & Mass Spectrometry
18th International Conference on
August 29-30, 2018 | Toronto, Canada
&
Overcoming challenges in the analysis of Cannabis and derived products
The imminent legal Cannabis Sector is projected to be worth 6 to 20 billion dollars in Canada alone. The highly regulated
nature of this sector demands rigorous quality control measures that require advanced analytical mass spectrometry and
other techniques to ensure product safety. The nature of the Cannabis plant and its current status as an illegal and controlled
narcotic in many countries, add a level of complexity to the development of analytical protocols. This talk will highlight some
of the challenges facing this sector and some of the approaches to overcome these. Specifically, issues with potency testing,
quantifying medicinal dose delivery, pesticide testing, development of Certified Reference Materials and the importance of ISO
17025 accreditation and international standard development will all be discussed.
Biography
Rob O'Brien, Ph.D., President and Chief Technology Officer, was a professor in Analytical Chemistry for over 13 years and has more than 25 years of experience
in analytical chemistry. An expert in analytical instrumentation, he has set up a number of advanced analytical laboratories and has held an executive position in a
number of commercial enterprises. Rob O'Brien possesses a track record of successful commercialization of intellectual property developed from academic research.
During his academic career, Rob O'Brien secured over 3 million dollars in research grants and has developed an extensive network of research collaborators.
Rob O’Brien
Supra Research and Development, Canada
Rob O’Brien, J Anal Bioanal Tech 2018, Volume 9
DOI: 10.4172/2155-9872-C1-026